Table 4.

Comparison of baseline demographics, clinical characteristics, and laboratory data (median and interquartile range with 25th and 75th percentiles for continuous variables and frequency and proportion for categorical variables) for patients with and without repeat FMT.

	No repeat FMT (N = 33)	Repeat FMT (N = 24)	P Value
Age (year)	72 (58 – 79)	74 (63 – 79)	0.71
Women	17 (51.5%)	17 (70.8%)	0.178
Severe/complicated CDI	21 (63.6%)	17 (70.8%)	0.777
WBC	15.1 (11.1 – 22)	22.6 (16.2 – 27.7)	0.02
Albumin	2.6 (2.3 – 2.8)	2.3 (2 – 2.6)	0.028
Number of CDI episodes	3 (2 – 4)	3 (2 – 4)	0.699
ICU admission	8 (24.2%)	11 (45.8%)	0.099
Presence of toxic megacolon	3 (9.1%)	6 (25%)	0.146
Acute renal failure	15 (45.5%)	11 (45.8%)	1
Pseudomembranes at first FMT	15 (45.5%)	20 (83.3%)	0.006
Charlson co-morbidity index	6 (4 – 8)	6 (5 – 7)	0.806
Immunosuppression	5 (15.2%)	5 (20.8%)	0.728
Use of non-anti CDI antibiotics during admission	11 (33.3%)	16 (66.7%)	0.017
Abdominal pain	25 (75.8%)	16 (66.7%)	0.554
Shock	5 (15.2%)	7 (29.2%)	0.324
Vasopressor use	6 (18.2%)	5 (20.8%)	1
Mechanical ventilation	1 (3%)	3 (12.5%)	0.3
Dialysis	5 (15.2%)	1 (4.2%)	0.385
Frozen stool	17 (51.5%)	11 (45.8%)	0.79
Use of stool from universal donor	26 (78.8%)	20 (83.3%)	0.745